| Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative … BJ Giantonio, PJ Catalano, NJ Meropol, PJ O'Dwyer, EP Mitchell, ... Journal of clinical oncology 25 (12), 1539-1544, 2007 | 2865 | 2007 |
| Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089 TE Le Voyer, ER Sigurdson, AL Hanlon, RJ Mayer, JS Macdonald, ... Journal of clinical oncology 21 (15), 2912-2919, 2003 | 1437 | 2003 |
| Patients' expectations about effects of chemotherapy for advanced cancer JC Weeks, PJ Catalano, A Cronin, MD Finkelman, JW Mack, NL Keating, ... New England Journal of Medicine 367 (17), 1616-1625, 2012 | 1323 | 2012 |
| Molecular predictors of survival after adjuvant chemotherapy for colon cancer T Watanabe, TT Wu, PJ Catalano, T Ueki, R Satriano, DG Haller, ... New England Journal of Medicine 344 (16), 1196-1206, 2001 | 1097 | 2001 |
| Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group … JD Berlin, P Catalano, JP Thomas, JW Kugler, DG Haller, AB Benson III Journal of Clinical Oncology 20 (15), 3270-3275, 2002 | 933 | 2002 |
| Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials DJ Sargent, HS Wieand, DG Haller, R Gray, JK Benedetti, M Buyse, ... Journal of Clinical Oncology 23 (34), 8664-8670, 2005 | 792 | 2005 |
| Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study DN Cagney, AM Martin, PJ Catalano, AJ Redig, NU Lin, EQ Lee, PY Wen, ... Neuro-oncology 19 (11), 1511-1521, 2017 | 656 | 2017 |
| Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma DA Braun, Y Hou, Z Bakouny, M Ficial, M Sant’Angelo, J Forman, ... Nature medicine 26 (6), 909-918, 2020 | 625 | 2020 |
| Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes AC Berger, ER Sigurdson, T LeVoyer, A Hanlon, RJ Mayer, JS Macdonald, ... Journal of clinical oncology 23 (34), 8706-8712, 2005 | 625 | 2005 |
| Using time-and size-resolved particulate data to quantify indoor penetration and deposition behavior CM Long, HH Suh, PJ Catalano, P Koutrakis Environmental science & technology 35 (10), 2089-2099, 2001 | 567 | 2001 |
| Relative contribution of outdoor and indoor particle sources to indoor concentrations E Abt, HH Suh, P Catalano, P Koutrakis Environmental science & technology 34 (17), 3579-3587, 2000 | 537 | 2000 |
| Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with … E Poplin, Y Feng, J Berlin, ML Rothenberg, H Hochster, E Mitchell, ... Journal of clinical oncology 27 (23), 3778-3785, 2009 | 528 | 2009 |
| Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089 DG Haller, PJ Catalano, JS Macdonald, MA O'Rourke, MS Frontiera, ... Journal of Clinical Oncology 23 (34), 8671-8678, 2005 | 506 | 2005 |
| Impact of diabetes mellitus on outcomes in patients with colon cancer JA Meyerhardt, PJ Catalano, DG Haller, RJ Mayer, JS Macdonald, ... Journal of Clinical Oncology 21 (3), 433-440, 2003 | 500 | 2003 |
| Phase II/III study of doxorubicin with fluorouracil compared with streptozocin with fluorouracil or dacarbazine in the treatment of advanced carcinoid tumors: Eastern … W Sun, S Lipsitz, P Catalano, JA Mailliard, DG Haller Journal of Clinical Oncology 23 (22), 4897-4904, 2005 | 429 | 2005 |
| High-dose bevacizumab improves survival when combined with FOLFOX4 in previously treated advanced colorectal cancer: results from the Eastern Cooperative Oncology Group (ECOG … BJ Giantonio, PJ Catalano, NJ Meropol, PJ O’dwyer, EP Mitchell, ... Journal of Clinical Oncology 23 (16_suppl), 2-2, 2005 | 406 | 2005 |
| Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology … CR Nichols, PJ Catalano, ED Crawford, NJ Vogelzang, LH Einhorn, ... Journal of Clinical Oncology 16 (4), 1287-1293, 1998 | 406 | 1998 |
| Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins MA Smith, L Rubinstein, JR Anderson, D Arthur, PJ Catalano, B Freidlin, ... Journal of Clinical Oncology 17 (2), 569-569, 1999 | 368 | 1999 |
| Influence of body mass index on outcomes and treatment‐related toxicity in patients with colon carcinoma JA Meyerhardt, PJ Catalano, DG Haller, RJ Mayer, AB Benson III, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2003 | 362 | 2003 |
| Mechanisms of morbidity and mortality from exposure to ambient air particles. JJ Godleski, RL Verrier, P Koutrakis, P Catalano, B Coull, U Reinisch, ... Research Report (Health Effects Institute), 5-88; discussion 89, 2000 | 356 | 2000 |
